SG11201700059WA - Therapeutic agent for keratoconjunctive disorder - Google Patents

Therapeutic agent for keratoconjunctive disorder

Info

Publication number
SG11201700059WA
SG11201700059WA SG11201700059WA SG11201700059WA SG11201700059WA SG 11201700059W A SG11201700059W A SG 11201700059WA SG 11201700059W A SG11201700059W A SG 11201700059WA SG 11201700059W A SG11201700059W A SG 11201700059WA SG 11201700059W A SG11201700059W A SG 11201700059WA
Authority
SG
Singapore
Prior art keywords
therapeutic agent
keratoconjunctive disorder
keratoconjunctive
disorder
therapeutic
Prior art date
Application number
SG11201700059WA
Other languages
English (en)
Inventor
Shinichiro Kaneko
Masaaki Sasaoka
Takashi Nagano
Satoshi Shirae
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SG11201700059WA publication Critical patent/SG11201700059WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201700059WA 2014-07-14 2015-07-13 Therapeutic agent for keratoconjunctive disorder SG11201700059WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014144555 2014-07-14
PCT/JP2015/069996 WO2016009982A1 (ja) 2014-07-14 2015-07-13 角結膜障害治療剤

Publications (1)

Publication Number Publication Date
SG11201700059WA true SG11201700059WA (en) 2017-02-27

Family

ID=55078475

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700059WA SG11201700059WA (en) 2014-07-14 2015-07-13 Therapeutic agent for keratoconjunctive disorder

Country Status (15)

Country Link
US (1) US20170182085A1 (ru)
EP (1) EP3150211B1 (ru)
JP (1) JP6779599B2 (ru)
KR (1) KR20170030494A (ru)
CN (1) CN106535904A (ru)
BR (1) BR112017000539A2 (ru)
CA (1) CA2954347A1 (ru)
EA (1) EA201700060A1 (ru)
ES (1) ES2688205T3 (ru)
MX (1) MX2017000474A (ru)
PH (1) PH12017500071A1 (ru)
SG (1) SG11201700059WA (ru)
TW (1) TW201625277A (ru)
UA (1) UA118228C2 (ru)
WO (1) WO2016009982A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906013A1 (en) * 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
CN113101299A (zh) * 2021-03-04 2021-07-13 圣珂兰投资有限公司 水前寺蓝藻多糖在制备治疗烫伤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006137426A1 (ja) * 2005-06-22 2009-01-22 興和株式会社 角結膜疾患の予防又は治療剤
US8350024B2 (en) 2006-11-22 2013-01-08 Tatsuo Kaneko Sugar derivatives and application of same
JP2009221136A (ja) * 2008-03-14 2009-10-01 Tatsuo Kaneko 糖誘導体製剤
JP2011068606A (ja) 2009-09-25 2011-04-07 Kumamoto Univ 徐放性担体及び同徐放性担体を用いた薬剤並びに同薬剤を用いたドラッグデリバリーシステム

Also Published As

Publication number Publication date
CA2954347A1 (en) 2016-01-21
CN106535904A (zh) 2017-03-22
WO2016009982A1 (ja) 2016-01-21
JP6779599B2 (ja) 2020-11-04
UA118228C2 (uk) 2018-12-10
EA201700060A1 (ru) 2017-10-31
ES2688205T3 (es) 2018-10-31
BR112017000539A2 (pt) 2018-06-26
JP2016029030A (ja) 2016-03-03
EP3150211B1 (en) 2018-08-15
EP3150211A1 (en) 2017-04-05
US20170182085A1 (en) 2017-06-29
PH12017500071A1 (en) 2017-05-15
KR20170030494A (ko) 2017-03-17
MX2017000474A (es) 2017-04-27
TW201625277A (zh) 2016-07-16
EP3150211A4 (en) 2017-06-28

Similar Documents

Publication Publication Date Title
IL250685A0 (en) Medicinal substance induces cytotoxicity
PT3132034T (pt) Terapêutica
IL250387A0 (en) combined treatment
GB201410816D0 (en) Therapeutic agents
GB201405033D0 (en) Combination therapy
HK1215864A1 (zh) 用於埋線療法的套管
GB201415569D0 (en) Therapeutic Compounds
ZA201702522B (en) Combination therapy
GB201410216D0 (en) Therapeutic
GB201410817D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
GB201510637D0 (en) Therapeutic
GB201416273D0 (en) Therapeutic compounds
GB201416788D0 (en) Therapeutic applications for pyocins
IL250160A0 (en) medicinal substance
ZA201608217B (en) Combination therapy
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
GB201911521D0 (en) Therapeutic agent
GB201516109D0 (en) Therapeutic agent
GB201421879D0 (en) Therapeutic agents
GB201421715D0 (en) Therapeutic agents
GB201418508D0 (en) Therapeutic
GB201409241D0 (en) Therapeutic agents
GB201409244D0 (en) Therapeutic agents
GB201413719D0 (en) Therapeutic